Heidi Oi-Yee Li

Heidi Oi-Yee Li

Auto-generated profile, based on publicly available information

Heidi Oi-Yee Li

Division of Dermatology, The Ottawa Hospital, University of Ottawa, ON, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2020 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
HLHeidi Oi-Yee Li
Heidi Oi-Yee Li
ABAdrian Bailey
Adrian Bailey
DHDavid Huynh
David Huynh
JCJames Chan
James Chan
Introduction The COVID-19 pandemic is this century’s largest public health emergency and its successful management relies on the effective dissemination of factual information. As a social media platform with billions of daily views, YouTube has tremendous potential to both support and hinder public health efforts. However, the usefulness and accuracy of most viewed YouTube videos on COVID-19 have not been investigated. Methods A YouTube search was performed on 21 March 2020 using keywords ‘coronavirus’ and ‘COVID-19’, and the top 75 viewed videos from each search were analysed. Videos that were duplicates, non-English, non-audio and non-visual, exceeding 1 hour in duration, live and unrelated to COVID-19 were excluded. Two reviewers coded the source, content and characteristics of included videos. The primary outcome was usability and reliability of videos, analysed using the novel COVID-19 Specific Score (CSS), modified DISCERN (mDISCERN) and modified JAMA (mJAMA) scores. Results Of 150 videos screened, 69 (46%) were included, totalling 257 804 146 views. Nineteen (27.5%) videos contained non-factual information, totalling 62 042 609 views. Government and professional videos contained only factual information and had higher CSS than consumer videos (mean difference (MD) 2.21, 95% CI 0.10 to 4.32, p=0.037); mDISCERN scores than consumer videos (MD 2.46, 95% CI 0.50 to 4.42, p=0.008), internet news videos (MD 2.20, 95% CI 0.19 to 4.21, p=0.027) and entertainment news videos (MD 2.57, 95% CI 0.66 to 4.49, p=0.004); and mJAMA scores than entertainment news videos (MD 1.21, 95% CI 0.07 to 2.36, p=0.033) and consumer videos (MD 1.27, 95% CI 0.10 to 2.44, p=0.028). However, they only accounted for 11% of videos and 10% of views. Conclusion Over one-quarter of the most viewed YouTube videos on COVID-19 contained misleading information, reaching millions of viewers worldwide. As the current COVID-19 pandemic worsens, public health agencies must better use YouTube to deliver timely and accurate information and to minimise the spread of misinformation. This may play a significant role in successfully managing the COVID-19 pandemic.

20 June 2019 in Journal of Cutaneous Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
HLHeidi Li
Heidi Li
SCSophia Colantonio
Sophia Colantonio
ADAndrea Dawson
Andrea Dawson
XLXing Lin
Xing Lin
JBJennifer Beecker
Jennifer Beecker
Recently in Canada, there has been an effort to create consistent messaging about sun safety as there is a lack of up-to-date evidence-based guidelines regarding sun-protection measures. This review aimed to provide updated, evidence-based recommendations on sunscreen application, safety, and sun protection regarding the following topics for which there is clinical uncertainty: physical barriers, sunscreen properties, sunscreen application, and risk-benefit analysis.

9 March 2022 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
HLHeidi Oi-Yee Li
Heidi Oi-Yee Li
EPElena Pastukhova
Elena Pastukhova
OBOlivier Brandts-Longtin
Olivier Brandts-Longtin
MTMarcus G Tan
Marcus G Tan
MKMark G Kirchhof
Mark G Kirchhof
Introduction: Vaccines for SARS-CoV-2 have been accessible to the public since December 2020. However, only 58.3% of Americans are fully vaccinated as of 5 November 2021. Numerous studies have supported YouTube as a source of both reliable and misleading information during the COVID-19 pandemic. Misinformation regarding the safety and efficacy of COVID-19 vaccines has negatively impacted vaccination intent. To date, the literature lacks a systematic evaluation of YouTube’s content on COVID-19 vaccination using validated scoring tools. The objective of this study was to evaluate the accuracy, usability and quality of the most widely viewed YouTube videos on COVID-19 vaccination. Methods: A search on YouTube was performed on 21 July 2021, using keywords ‘COVID-19 vaccine’ on a cleared-cache web browser. Search results were sorted by ‘views’, and the top 150 most-viewed videos were collected and analysed. Duplicate, non-English, non-audiovisual, exceeding 1-hour duration, or videos unrelated to COVID-19 vaccine were excluded. The primary outcome was usability and reliability of videos, analysed using the modified DISCERN (mDISCERN) score, the modified Journal of the American Medical Association (mJAMA) score and the COVID-19 Vaccine Score (CVS). Results: Approximately 11% of YouTube’s most viewed videos on COVID-19 vaccines, accounting for 18 million views, contradicted information from the WHO or the Centers for Disease Control and Prevention. Videos containing non-factual information had significantly lower mDISCERN (p<0.001), mJAMA (p<0.01) and CVS (p<0.001) scores compared with videos with factual information. Videos from government sources had higher mJAMA and CVS scores, but averaged three times the ratio of dislikes to likes, while videos containing non-factual information averaged 14 times more likes than dislikes. Conclusion: As the COVID-19 pandemic evolves, widespread adoption of vaccination is essential in reducing morbidity, mortality, and returning to some semblance of normalcy. Providing high-quality and engaging health information from reputable sources is essential in addressing vaccine hesitancy.

10 September 2019 in Journal of Cutaneous Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
HLHeidi Oi-Yee Li
Heidi Oi-Yee Li
SCSophia Colantonio
Sophia Colantonio
MRMichele L. Ramien
Michele L. Ramien
Mycoplasma pneumoniae-induced rash and mucositis (MIRM) is a relatively newly recognized clinical entity that typically presents with predominant mucositis accompanied by variable cutaneous involvement 7-9 days after the onset of prodromal symptoms. There are no evidence-based guidelines for treatment, and current standards of care may include supportive therapy, antibiotics, corticosteroids, and intravenous immunoglobulin . This case series aims to describe the potential efficacy of cyclosporine A (CsA) in the treatment of MIRM. The present case series details our use of CsA early in the course of MIRM in 3 pediatric patients. Rapid clinical resolution was observed following CsA therapy. We suggest that early initiation of CsA may be an effective therapeutic option for MIRM.

21 September 2020 in Journal of Cutaneous Medicine and Surgery
Verified
Journal Article
Closed access
PDF file
HLHeidi Oi-Yee Li
Heidi Oi-Yee Li
ABAdrian Joseph-Michel Bailey
Adrian Joseph-Michel Bailey
EGElysia Grose
Elysia Grose
JMJames Ted McDonald
James Ted McDonald
AQAlexandra Quimby
Alexandra Quimby
CNCarolyn Nessim
Carolyn Nessim
As melanoma is one of the leading cancers in average years of life lost per death from disease, screening and early diagnosis are imperative to decrease morbidity and mortality. Socioeconomic status (SES) has been shown to be associated with melanoma incidence. However, it is unclear if this association holds true in universal healthcare systems where screening, diagnostic, and treatment services are available to all patients. The objective of this systematic review was to evaluate the evidence on the association of SES and melanoma incidence in Canada. A comprehensive search of PubMed and EMBASE yielded 7 studies reporting on melanoma incidence or outcomes with respect to SES in Canada. High SES was associated with increased melanoma incidence across all studies, which encompassed all Canadian provinces, and time periods spanning from 1979 to 2012. Studies also reported an increasing incidence of melanoma over time. There were substantial discrepancies in melanoma incidence across Canadian provinces, after controlling for SES and demographic characteristics. Populations of lower SES and living within certain healthcare regions had increased risks of advanced melanoma at diagnosis. This review highlights the potential for inequities in access to care even within a universal healthcare system. Future research is needed to characterize specific risk factors within different patient groups and within the universal health system context in order to implement targeted strategies to lower melanoma incidence, morbidity, and mortality.

8 July 2020 in Academic Medicine
Verified
Journal Article
Closed access
HLHeidi Oi-Yee Li
Heidi Oi-Yee Li
ABAdrian M.J. Bailey
Adrian M.J. Bailey
An abstract is unavailable. This article is available as a PDF only.